Prenatal diagnosis and management of high-grade cervical neuroendocrine carcinoma: A case report

High-grade neuroendocrine carcinoma of the cervix is a rare and aggressive malignancy, accounting for less than 2 % of all cervical cancers. Its occurrence during pregnancy is exceptional, with only 21 cases reported in the literature to date. This report presents the case of a 25-year-old primigravida diagnosed at 29.5 weeks of gestation with a high-grade small cell neuroendocrine carcinoma of the cervix, confirmed by histopathology and immunohistochemistry. The patient was initially managed conservatively, but tumor progression prompted delivery by cesarean section at 31 weeks, followed by immediate modified radical hysterectomy, bilateral pelvic lymphadenectomy, and partial omentectomy. Adjuvant chemotherapy with cisplatin and etoposide was administered. Pathological evaluation confirmed the diagnosis, with no lymph node or omental metastases. A comprehensive review of the literature identified 21 similar cases, highlighting the lack of standardized treatment protocols for this population. Multidisciplinary coordination was essential for balancing maternal oncologic priorities with fetal outcomes. This case contributes to the limited data on neuroendocrine cervical carcinoma in pregnancy and reinforces the importance of individualized, team-based management.